Effect of Genital Sampling Site on the Detection and Quantification of Ureaplasma Species with Quantitative Polymerase Chain Reaction during Pregnancy.
Gilles FaronEllen VancutsemAnne NaessensRonald BuylLeonardo GucciardoWalter FoulonPublished in: Infectious diseases in obstetrics and gynecology (2017)
Objective. This study aimed to compare the qualitative and quantitative reproducibility of quantitative PCR (qPCR) for Ureaplasma species (Ureaplasma spp.) throughout pregnancy and according to the genital sampling site. Study Design. Between 5 and 14 weeks of gestation (T1), vaginal, fornix, and two cervical samples were taken. Sampling was repeated during the 2nd (T2) and 3rd (T3) trimester in randomly selected T1 positive and negative women. Qualitative and quantitative reproducibility were evaluated using, respectively, Cohen's kappa (κ) and interclass correlation coefficients (ICC) and repeated measures ANOVA on the log-transformed mean number of DNA copies for each sampling site. Results. During T1, 51/127 women were positive for U. parvum and 8 for U. urealyticum (4 patients for both). Sampling was repeated for 44/55 women at T2 and/or T3; 43 (97.7%) remained positive at the three timepoints. κ ranged between 0.83 and 0.95 and the ICC for cervical samples was 0.86. Conclusions. Colonization by Ureaplasma spp. seems to be very constant during pregnancy and vaginal samples have the highest detection rate.
Keyphrases
- pregnancy outcomes
- polycystic ovary syndrome
- high resolution
- end stage renal disease
- preterm birth
- gestational age
- real time pcr
- ejection fraction
- pregnant women
- cervical cancer screening
- systematic review
- chronic kidney disease
- breast cancer risk
- loop mediated isothermal amplification
- preterm infants
- peritoneal dialysis
- nuclear factor
- type diabetes
- adipose tissue
- circulating tumor
- insulin resistance
- prognostic factors
- toll like receptor
- cell free